NB
FTXH icon

NBT Bank’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

NBT Bank’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-750
Closed -$44.4K – 822
2024
Q3 		$44.4K Buy
+750
New +$21.5K ﹤0.01% 535

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NBT Bank's FTXH Position: Q4 2024 in Review

NBT Bank sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2024, closing a stake of 750 shares — an estimated $44.4K sold.

NBT Bank first reported a position in FTXH in Q3 2024 and held it in 1 quarter. The position peaked at $44.4K in Q3 2024. 21 funds tracked by Wall St. Rank hold FTXH as of Q4 2024.

  • NBT Bank reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
  • NBT Bank sold 750 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2024, an estimated $44.4K.
  • NBT Bank first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2024 and held it in 1 quarter.
  • NBT Bank's First Trust Nasdaq Pharmaceuticals ETF position peaked at $44.4K in Q3 2024.
  • 21 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2024.

Based on NBT Bank's 13F filing for Q4 2024, filed 7 Feb 2025.